Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
Shen ZJ, García-García HM, Garg S, Onuma Y, Schenkeveld L, van Domburg RT, Serruys PW; Interventional Cardiologists at Thoraxcentre in 2000-2003. Shen ZJ, et al. Among authors: garg s. Catheter Cardiovasc Interv. 2009 Dec 1;74(7):979-86. doi: 10.1002/ccd.22230. Catheter Cardiovasc Interv. 2009. PMID: 19753636
Fractional flow reserve for guiding PCI.
Garg S, Rademaker T, Serruys P. Garg S, et al. N Engl J Med. 2009 May 7;360(19):2025-6; author reply 2026-7. N Engl J Med. 2009. PMID: 19425236 No abstract available.
Assessment of the SYNTAX score in the Syntax study.
Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW. Serruys PW, et al. Among authors: garg s. EuroIntervention. 2009 May;5(1):50-6. doi: 10.4244/eijv5i1a9. EuroIntervention. 2009. PMID: 19577983
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
Garg S, Serruys P, Onuma Y, Dorange C, Veldhof S, Miquel-Hébert K, Sudhir K, Boland J, Huber K, Garcia E, te Riele JA; SPIRIT II Investigators. Garg S, et al. JACC Cardiovasc Interv. 2009 Dec;2(12):1190-8. doi: 10.1016/j.jcin.2009.10.002. JACC Cardiovasc Interv. 2009. PMID: 20129545 Free article. Clinical Trial.
How should I treat a complex Post-CABG patient?
Sarno G, Schultz C, Garg S, Ligthart J, Garcia HM, Serruys PW. Sarno G, et al. Among authors: garg s. EuroIntervention. 2009 Nov;5(5):627-32. doi: 10.4244/eijv5i5a100. EuroIntervention. 2009. PMID: 20142185
4,361 results